Bausch & Lomb (BLCO) FCF Margin (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly FCF Margin came in at 5.88% in Q2 2026, up 1011.0% on a YoY basis from 0.53% in Q2 2025, and up 207.61% quarter-over-quarter from 5.47% in Q1 2026.
Powered by 
Analysis
Bausch & Lomb (BLCO) FCF Margin (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has reported FCF Margin for 6 consecutive years, with 5.88% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, FCF Margin rose 1011.0% year-over-year to 5.88%; the trailing twelve-month figure through Jun 2026 stood at 2.57% (up 595.0% YoY), and the FY2025 full-year result was 1.29%, down 6.0% from the prior year.
- FCF Margin grew to 5.88% in Q2 2026 per BLCO's latest filing, from 5.47% in the prior quarter.
- Across five years, FCF Margin topped out at 12.96% in Q2 2022 and bottomed at 11.87% in Q1 2025.
- Historically, FCF Margin has averaged 0.74% across 5 years, with a median of 3.3% in 2024.
- The sharpest annual moves came in 2022 and 2026: FCF Margin plunged 2678 bps in 2022, then surged 1011 bps in 2026.
- Over 5 years, FCF Margin stood at 10.94% in 2022, then slumped by 154 bps to 5.88% in 2023, then rose by 7 bps to 5.47% in 2024, then soared by 178 bps to 4.27% in 2025, then soared by 38 bps to 5.88% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 5.88%, 5.47%, and 4.27% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 15.81% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 32.79% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 13.22% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 16.07% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 23.50% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 33.60% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 21.78% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 14.10% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 18.73% |
| 10 | Bausch & Lomb | 6.28 Bn | 5.90 Bn | 867.00 Mn | 5.88% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.88% |
| Mar 31, 2026 | -5.47% |
| Dec 31, 2025 | 4.27% |
| Sep 30, 2025 | 4.92% |
| Jun 30, 2025 | -4.23% |
| Mar 31, 2025 | -11.87% |
| Dec 31, 2024 | -5.47% |
| Sep 30, 2024 | 7.86% |
| Jun 30, 2024 | -4.69% |
| Mar 31, 2024 | -2.37% |
| Dec 31, 2023 | -5.88% |
| Sep 30, 2023 | 1.49% |
| Jun 30, 2023 | -4.93% |
| Mar 31, 2023 | -9.99% |
| Dec 31, 2022 | 10.94% |
| Sep 30, 2022 | -2.34% |
| Jun 30, 2022 | 12.96% |
| Mar 31, 2022 | -4.39% |
| Dec 31, 2021 | 9.99% |
| Sep 30, 2021 | 24.45% |